IMMUNO-model Webinar 02: imSAVAR project: Nonclinical mimicking of the immune system effects of immunomodulatory therapies

IMMUNO-model Webinar 02: imSAVAR project: Nonclinical mimicking of the immune system effects of immunomodulatory therapies

Share this post

Facebook
Twitter
LinkedIn
WhatsApp

2nd IMMUNO-model webinar entitled “imSAVAR project: Nonclinical mimicking of the immune system effects of immunomodulatory therapies” was streamed live on the ZOOM platform on May 6th, 2024 at 2.00 pm CET.

The webinar consisted of two presentations and a question and answer session:

  • Marek Ostaszewski, Luxembourg Centre forSystems Biomedicine, University of Luxembourg

Construction, visual exploration and analytics of irAOP systems biology diagrams

  • Katherina Sewald, Fraunhofer ITEM, Germany

Immune-related adverse outcome pathways for regulatory decision making

The webinar was moderated by dr. Christina Sakellarious, Lund University, Sweden, and prof. Rosalinda Sorrentino, IMMUNO-model WG5 co-Leader, University of Salerno, Italy.

Check out Webinar here.

For further information, please contact the IMMUNO-model Science Communication Coordinator Dr. Barbara Breznik (barbara.breznik@nib.si).

Latest Updates

20-22 May 2026, Ljubljana, Slovenia Venue: National Institute of Biology, 121 Vecna pot, 1000 Ljubljana, Slovenia Scientific Committee (SC)Eva Martinez-Balibrea, Germans Trias i Pujol Research Institute, SpainVinton Cheng, University of...
We’re excited to share the latest addition to the IMMUNOmodel Knowledge Hub: 👉 “Dual ultralow and Matrigel protocol for establishment of glioma organoids” by Maria Dudău and colleagues. This step-by-step...
During my research stay in Dr. Calvin Kuo’s laboratory at Stanford University, I received advanced training in patient-derived tumour models that preserve the tumour microenvironment. I learned how to establish...
During my two-month STSM at IPBS Toulouse, I gained hands-on experience in spectral flow cytometry and intravital microscopy for studying immune responses following electrochemotherapy. Using syngeneic mouse tumor models, we...
Grantee name: Simona Kranjc BrezarStart and end date: 1.4.2026-31.5.2026 During my two-month STSM at IPBS Toulouse, I gained hands-on experience in spectral flow cytometry and intravital microscopy for studying immune...
Conference title: ESMO Immuno-Oncology Congress 2025Conference web-page: https://www.esmo.org/meeting-calendar/esmo-immuno-oncology-congress-2025 Conference venue: Queen Elizabeth II Centre in London, United Kingdom. Conference start and end date: 10/12/2025 to 12/12/2025 Title of the presentation:...

Join us

How to Participate

The COST Action IMMUNO-model welcomes research-active scientists working in the field.

How to Get Involved

  • Read the Project Description MoU;
  •  Inform the Main Proposer/Chair of your interest (email);
  • Apply to join your Working Groups of interest;
  • You will be informed by the working group leaders as soon as your application has been reviewed;
  • Please note, Management Committee nominations are carried out through the COST National Contact Points.

How to participate in an existing Action?

If you would like to join this COST Action please ensure that you read the guidance notes published on the COST website. You can find full documentation regarding general rules and guidelines for COST Actions at www.cost.eu/participate.

Subscribe to our newsletter